Evidence map›Paper›PMID 26740655›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2016

Enhanced Store-Operated Calcium Entry Leads to Striatal Synaptic Loss in a Huntington's Disease Mouse Model.

Jun Wu, Daniel A Ryskamp, Xia Liang, Polina Egorova, Olga Zakharova, Gene Hung, Ilya Bezprozvanny

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 83 papers.

0numbers the graph read from it
0cells of the map it votes in
83citing papers in PubMed
9.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

83 citing papers in PubMed, 128 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Neuronal Calcium Signaling and Cytoskeletal Dynamics in Neurodegeneration.International journal of molecular sciences · 2026
    Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Calcium Ions in the Physiology and Pathology of the Central Nervous System.International journal of molecular sciences · 2024
    Review
  11. Review
  12. Review
  13. SOCE as a regulator of neuronal activity.The Journal of physiology · 2024
    Review
  14. Review
  15. Neuronal Store-Operated Calcium Channels.Molecular neurobiology · 2023
    Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

23 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Jun WuDepartment of Physiology, University of Texas Southwestern Medical Center, Dallas, Texas 75390.
Daniel A RyskampDepartment of Physiology, University of Texas Southwestern Medical Center, Dallas, Texas 75390.ORCID http://orcid.org/0000-0002-2197-0730
Xia LiangDepartment of Physiology, University of Texas Southwestern Medical Center, Dallas, Texas 75390.
Polina EgorovaLaboratory of Molecular Neurodegeneration, St. Petersburg State Polytechnical University, St. Petersburg 195251, Russia, and.
Olga ZakharovaLaboratory of Molecular Neurodegeneration, St. Petersburg State Polytechnical University, St. Petersburg 195251, Russia, and.ORCID http://orcid.org/0000-0002-2384-0681
Gene HungIsis Pharmaceuticals, Inc., Carlsbad, California 92010.
Ilya BezprozvannyDepartment of Physiology, University of Texas Southwestern Medical Center, Dallas, Texas 75390, Laboratory of Molecular Neurodegeneration, St. Petersburg State Polytechnical University, St. Petersburg 195251, Russia, and Ilya.Bezprozvanny@UTSouthwestern.edu.
Peter the Great St. Petersburg Polytechnic University · RUThe University of Texas Southwestern Medical Center · USIonis Pharmaceuticals (United States) · US

Funding

Deranged calcium signaling and polyglutamine expansion disordersR01NS056224 · NINDS · UT SOUTHWESTERN MEDICAL CENTER · PI BEZPROZVANNY, ILYA B · 2008 to 2020
$3.5M
Calcium channels as novel therapeutic targets for Huntingtons DiseaseR01NS074376 · NINDS · UT SOUTHWESTERN MEDICAL CENTER · PI BEZPROZVANNY, ILYA B · 2012 to 2015
$1.4M
Synaptic calcium dysregulation in Huntington's diseaseF32NS093786 · NINDS · UT SOUTHWESTERN MEDICAL CENTER · PI RYSKAMP, DANIEL AARON · 2015 to 2017
$174k
NINDS NIH HHS F32 NS093786NINDS NIH HHS F32NS093786NINDS NIH HHS R01 NS056224NINDS NIH HHS R01NS056224NINDS NIH HHS R01 NS074376NINDS NIH HHS R01NS074376
6 · The paper itself

Abstract

In Huntington's disease (HD), mutant Huntingtin (mHtt) protein causes striatal neuron dysfunction, synaptic loss, and eventual neurodegeneration. To understand the mechanisms responsible for synaptic loss in HD, we developed a corticostriatal coculture model that features age-dependent dendritic spine loss in striatal medium spiny neurons (MSNs) from YAC128 transgenic HD mice. Age-dependent spine loss was also observed in vivo in YAC128 MSNs. To understand the causes of spine loss in YAC128 MSNs, we performed a series of mechanistic studies. We previously discovered that mHtt protein binds to type 1 inositol (1,4,5)-trisphosphate receptor (InsP3R1) and increases its sensitivity to activation by InsP3. We now report that the resulting increase in steady-state InsP3R1 activity reduces endoplasmic reticulum (ER) Ca(2+) levels. Depletion of ER Ca(2+) leads to overactivation of the neuronal store-operated Ca(2+) entry (nSOC) pathway in YAC128 MSN spines. The synaptic nSOC pathway is controlled by the ER resident protein STIM2. We discovered that STIM2 expression is elevated in aged YAC128 striatal cultures and in YAC128 mouse striatum. Knock-down of InsP3R1 expression by antisense oligonucleotides or knock-down or knock-out of STIM2 resulted in normalization of nSOC and rescue of spine loss in YAC128 MSNs. The selective nSOC inhibitor EVP4593 was identified in our previous studies. We now demonstrate that EVP4593 reduces synaptic nSOC and rescues spine loss in YAC128 MSNs. Intraventricular delivery of EVP4593 in YAC128 mice rescued age-dependent striatal spine loss in vivo. Our results suggest EVP4593 and other inhibitors of the STIM2-dependent nSOC pathway as promising leads for HD therapeutic development. SIGNIFICANCE STATEMENT: In Huntington's disease (HD) mutant Huntingtin (mHtt) causes early corticostriatal synaptic dysfunction and eventual neurodegeneration of medium spine neurons (MSNs) through poorly understood mechanisms. We report here that corticostriatal cocultures prepared from YAC128 HD mice feature age-dependent MSN spine loss, mirroring YAC128 MSN spine loss in vivo. This finding establishes a system for mechanistic studies of synaptic instability in HD. We use it to demonstrate that sensitization of type 1 inositol (1,4,5)-trisphosphate receptors by mHtt, which depletes endoplasmic reticulum calcium, contributes to synaptotoxic enhancement of STIM2-dependent store-operated calcium (SOC) entry. Treatment with EVP4593, a neuroprotective inhibitor of neuronal SOC channels, rescues YAC128 MSN spine loss both in vitro and in vivo. These results suggest that enhanced neuronal SOC causes synaptic loss in HD-afflicted MSNs.

Indexed as

Calcium SignalingAnimalsCalciumCells, CulturedCorpus StriatumHuntington DiseaseMiceMice, TransgenicSynapsesCalciumcalciumHuntingtinimagingsynapsetransgenic

Identifiers

PMID26740655
PMCPMC4701955
OpenAlexW2323193108

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.